#RikenVitaminCoLtd

For the third quarter of FY2026, consolidated net sales were 72,503 million yen (down 0.5% YoY), operating income was 5,716 million yen (down 24.2% YoY), and net income attributable to owners of the parent was 5,949 million yen (up 2.0% YoY).

Riken Vitamin Co., Ltd. announced a revision to its consolidated earnings guidance for the fiscal year ending March 2026, adjusting net sales to 96,000 million yen (down 4.0% from previous forecast), operating income to 6,200 million yen (down 27.1%), and net income attributable to owners of parent to 6,500 million yen (down 20.7%).

For Q3 FY2025, consolidated net sales were JPY 72,503 million (YoY -0.5%), operating income was JPY 5,716 million (YoY -24.2%), and net income was JPY 5,949 million (YoY +2.0%).

Acquired 62,200 shares of treasury stock totaling 190,219,693 yen from January 1 to January 31, 2026. The cumulative number of shares acquired is 585,900, with a total acquisition cost of 1,664,751,327 yen.